SCHEMBL6785648

SCHEMBL6785648

CCc1ccc2c(=O)c3c(cnn3C)[nH]c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.47
CCNE2 O96020 1/20 0.40
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
PRMT5 O14744 3/20 0.39
WDR77 Q9BQA1 3/20 0.39
DAO P14920 1/20 0.37
PTGES O14684 1/20 0.37
CYP2C9 P11712 1/20 0.37
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PARP1 P09874 2/20 0.35
KCNH2 Q12809 2/20 0.35
PARP2 Q9UGN5 2/20 0.35
PDE9A O76083 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6789023 0.89 SMN1; SMN2 (0.47) KIF11PRMT5WDR77KDM4ENPC1
SCHEMBL6783202 0.81 FEN1 (0.42) KIF11CCNE2CDK4CCND1CCNE1
SCHEMBL6791609 0.78 TBK1 (0.48) KIF11CDK2PRMT5WDR77KDM4E
SCHEMBL13560650 0.76 KIF11 (0.61) KIF11CCNE2CDK4CCND1CCNE1
SCHEMBL6792539 0.76 GRIN2D (0.36) PRMT5WDR77KDM4ENPC1ALDH1A1
SCHEMBL6785795 0.74 GABRA1 (0.44) KIF11KDM4EALDH1A1MAPK1
SCHEMBL6787118 0.74 MPO (0.38) DAOKDM4EALDH1A1HPGDHTT
SCHEMBL6782956 0.74 HTR1A (0.35) PRMT5WDR77KDM4ENPC1ALDH1A1
SCHEMBL6785384 0.74 CCNC (0.40) PRMT5WDR77CYP2C9ALDH1A1SMN1; SMN2
SCHEMBL6786766 0.74 PRMT5 (0.36) PRMT5WDR77CYP2C9KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686373-B2 ANALGESICS; ANTIINFLAMMATORY AGENT WARNER-LAMBERT COMPANY LLC 2004-02-03 US disclosed
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors KAWAMURA KIYOSHI (JP) 2003-07-10 US disclosed
EP-1310498-A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PFIZER INC. (US) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130277-A1 Pyrazoloquinolinone derivatives as protein kinase C inhibitors PRKCB, PRKCA, PRKCG KIF11 3685/4885CCNE2 2079/4885CDK4 1267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.